|
|
Gene Symbol |
GH1 |
|
Aliases |
GH, GH-N, GHB5, GHN, IGHD1A, IGHD1B, IGHD2, hGH-N |
|
Entrez Gene ID |
|
|
Gene Name |
Growth hormone 1 |
|
Chromosomal Location |
17q23.3 |
|
HGNC ID |
|
|
Summary |
The protein encoded by this gene is a member of the somatotropin/prolactin family of hormones which play an important role in growth control. The gene, along with four other related genes, is located at the growth hormone locus on chromosome 17 where they are interspersed in the same transcriptional orientation; an arrangement which is thought to have evolved by a series of gene duplications. The five genes share a remarkably high degree of sequence identity. Alternative splicing generates additional isoforms of each of the five growth hormones, leading to further diversity and potential for specialization. This particular family member is expressed in the pituitary but not in placental tissue as is the case for the other four genes in the growth hormone locus. Mutations in or deletions of the gene lead to growth hormone deficiency and short stature. [provided by RefSeq, Jul 2008]
|
|
RefSeq DNA |
|
|
RefSeq mRNA |
|
|
e!Ensembl
|
Gene Ontology (GO)
GO ID |
Ontology |
Function |
Evidence |
Reference |
GO:0002092 |
Biological process |
Positive regulation of receptor internalization |
IDA |
9360546 |
GO:0010536 |
Biological process |
Positive regulation of activation of Janus kinase activity |
IDA |
8063815, 12552091 |
GO:0010828 |
Biological process |
Positive regulation of glucose transmembrane transport |
IDA |
9144201 |
GO:0014068 |
Biological process |
Positive regulation of phosphatidylinositol 3-kinase signaling |
IDA |
7782332 |
GO:0031667 |
Biological process |
Response to nutrient levels |
IBA |
21873635 |
GO:0032355 |
Biological process |
Response to estradiol |
IDA |
12552091 |
GO:0040018 |
Biological process |
Positive regulation of multicellular organism growth |
IDA |
7565946, 20110402 |
GO:0040018 |
Biological process |
Positive regulation of multicellular organism growth |
IMP |
8496314 |
GO:0042531 |
Biological process |
Positive regulation of tyrosine phosphorylation of STAT protein |
IBA |
21873635 |
GO:0042531 |
Biological process |
Positive regulation of tyrosine phosphorylation of STAT protein |
IDA |
8923468, 12552091 |
GO:0043406 |
Biological process |
Positive regulation of MAP kinase activity |
TAS |
8063815 |
GO:0043568 |
Biological process |
Positive regulation of insulin-like growth factor receptor signaling pathway |
IDA |
7565946 |
GO:0045927 |
Biological process |
Positive regulation of growth |
IBA |
21873635 |
GO:0046427 |
Biological process |
Positive regulation of JAK-STAT cascade |
IBA |
21873635 |
GO:0046427 |
Biological process |
Positive regulation of JAK-STAT cascade |
IDA |
8063815, 8923468 |
GO:0048513 |
Biological process |
Animal organ development |
IBA |
21873635 |
GO:0050731 |
Biological process |
Positive regulation of peptidyl-tyrosine phosphorylation |
IBA |
21873635 |
GO:0050731 |
Biological process |
Positive regulation of peptidyl-tyrosine phosphorylation |
IDA |
7782332 |
GO:0060396 |
Biological process |
Growth hormone receptor signaling pathway |
IBA |
21873635 |
GO:0060396 |
Biological process |
Growth hormone receptor signaling pathway |
IDA |
8063815 |
GO:0070977 |
Biological process |
Bone maturation |
IDA |
20110402 |
GO:0005615 |
Cellular component |
Extracellular space |
IBA |
21873635 |
GO:0005615 |
Cellular component |
Extracellular space |
IDA |
11549663 |
GO:0062023 |
Cellular component |
Collagen-containing extracellular matrix |
HDA |
28327460 |
GO:0070195 |
Cellular component |
Growth hormone receptor complex |
IDA |
1549776, 8943276, 9571026 |
GO:0005131 |
Molecular function |
Growth hormone receptor binding |
IBA |
21873635 |
GO:0005131 |
Molecular function |
Growth hormone receptor binding |
IDA |
6303755 |
GO:0005131 |
Molecular function |
Growth hormone receptor binding |
IPI |
1549776, 2825030, 8943276, 9571026 |
GO:0005148 |
Molecular function |
Prolactin receptor binding |
IDA |
10890569 |
GO:0005148 |
Molecular function |
Prolactin receptor binding |
IPI |
7984244 |
GO:0005179 |
Molecular function |
Hormone activity |
IBA |
21873635 |
GO:0005515 |
Molecular function |
Protein binding |
IPI |
8943276, 9353194 |
GO:0008083 |
Molecular function |
Growth factor activity |
IBA |
21873635 |
GO:0008083 |
Molecular function |
Growth factor activity |
IPI |
9360546 |
|
Protein Information |
|
Protein Name |
Somatotropin, growth hormone B5, pituitary growth hormone |
|
Function |
Plays an important role in growth control. Its major role in stimulating body growth is to stimulate the liver and other tissues to secrete IGF-1. It stimulates both the differentiation and proliferation of myoblasts. It also stimulates amino acid uptake and protein synthesis in muscle and other tissues |
|
|
|
|
|
UniProt |
|
|
PDB |
|
|
Pfam |
Pfam Accession |
Pfam ID |
PF00103 |
Hormone_1 |
|
|
|
|
Interactions |
| |
STRING |
MINT |
IntAct |
ENSP00000320935 |
P14672 |
P14672 |
|
| |
View interactions
|
|
| |
Associated Diseases
Disease group | Disease Name | References |
Blood Disorders |
Polycythemia |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities |
Turner Syndrome |
|
Endocrine System Diseases |
Kowarski syndrome |
|
Growth Hormone Deficiency |
8496314, 10678654, 10689634, 12655557, 17785368, 9554464, 7714096, 12574219, 7567462, 10372722, 9578959, 10469016, 8530604, 8923859, 18785993, 10445339, 9175738, 11502836, 9152628 |
Acromegaly |
|
Ateleiotic dwarfism |
|
PCOS |
|
Neoplasms |
Pituitary Neoplasms |
|
Nutritional and Metabolic Diseases |
Obesity |
|
Psychiatric/Brain disorders |
Mental Depression |
|
Obstructive Sleep Apnea |
|
Renal Disorder |
Azotemia |
|
|
References |
|
|
|
PubMed ID |
Associated gene/s |
Associated condition |
Genetic Mutation |
Diagnostic Criteria |
Association with PCOS |
Ethnicity |
Conclusion |
|
|
|
|
|
Related
|
13 controls, 15 patients with PCOS |
Our findings suggest that the cause of susceptibility for GH secretion to be suppressed after glucose loading in non-obese PCOSpatients may be hyperandrogenemia |
|
INS, IGF-1 |
|
|
|
Direct
|
Women within the reproductive age range (21-43 years) with active acromegaly |
PCO and PCOSP are relatively common in women with acromegaly and may account for some of the symptoms related to gonadal dysfunction irrespective of the size of the pituitary tumour. It is likely that IGF-1 alone or in combination with GH and/or insulin resistance may be involved. |
|
|
|
|